Search

everythinglearnresearchcommunity

for

Search:↓

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

PPAR alpha may help in hair growth and could be a target for treatment.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Softer hydrogel surfaces help maintain hair growth-related functions in skin cells.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Understanding skin patterns can help us learn about skin diseases and their treatments.

Gender affects the symptoms and severity of systemic lupus erythematosus.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Finasteride exposure harms tadpole reproduction and hormone balance.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

The HR protein's role as a repressor is essential for controlling hair growth.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Shorter daylight increases hair growth in Cashmere goats.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

DHT deficiency increases iNOS expression in rat testis and epididymis.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.